Home › Targets › HTT

HTT (3 companies · 3 programs)

Companies with an active program directed at HTT.

Sarepta Therapeutics, Inc. SRPT

HTT siRNA — Huntington's Disease Preclinical

uniQure N.V. QURE

AMT-130 — Huntington's Disease Phase 1

Wave Life Sciences Ltd. WVE

WVE-003 — Huntington's Disease Phase 1